A bit scary but lots of fun!

Dawn Alba and I got together last Friday to trial our event later this month.

DSC_0043
With wigs by Dawn and make-up by yours truly we spent the morning working on an idea we had been thinking about for some time.  Now that we had found a venue which could work for us it was time to get going.

I know, and have lost, many girlfriends who have lost their hair during treatment for cancer and have wanted to do something to raise money for the fantastic work done and support given by Macmillan Cancer Support.  When Dawn and I met a few months ago and she told me about her new wig business, the opportunity presented itself.

Macmillan

It was quite scary seeing myself with long blonde hair – and I’m not sure about the lighter bob – it takes a bit of getting used to.  But in the spirit of walking the talk and getting out of my comfort zone we took some photos to show that, actually, its really fun to do.

Afterall, the great thing is that if you don’t like your hair and make-up, you can just take it off!

See the Events page for the results more details of the event.

Detecting early signs of cancer

I posted a short piece on Facebook about a week ago about new technology developments in cancer treatment.  It seems that this disease is raising it’s head and making me take notice more and more because I was reading the February edition of South East Business magazine today and came across an article about an innovation from Angle PLC.

Angle PLC has been working with Surrey University to develop a blood separation technique which, if successful, in a few years’ time will be used to take a simple blood test to show people whether they are at risk from cancer.

Read the whole article here (page 20)

The main application of the Parsortix separation device (quite a name!) is with known cancer patients in identifying whether they have secondary cancers and also to select the most effective chemotherapy drug for them.  Often patients are treated with three or four different drugs at the same time because cancers mutate and it isn’t known which drug will work.  These drugs have awful side effects and hopefully this technology will help identify the most effective drug and therefore help reduce the side effects.

The device is in the lab at the moment undergoing tests with ‘spiked’ blood (normal blood with cancer cells added) and will be tested with cancer patient blood.  The hope is that the final product will be ready for sale to research teams by the end of this year.  Two years after that the device will make its way into hospitals.

Angle PLC specialise in working with large research organisations and  creating businesses from them.  And reducing suffering – hooray to that!